Dr. Tomasz Kuliński among the laureates of the SONATINA scheme

Dr. Tomasz Kuliński will join our Institute with the grant received under SONATINA 3 scheme funded by the National Science Centre. Dr. Kuliński was awarded funding of 832 059 PLN for the project “How dysfunction in the nuclear, RNA degrading enzyme DIS3 leads to mitotic defects creating a possible therapeutic strategy for Multiple Myeloma”.

The complete list of beneficiaries can be found at NCN website.